← FDA Drug Approvals (Drugs@FDA)
ETHACRYNATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN INSTITUTIONAL · Approved 2016-08-23
Drug application
- FDA Application #
ANDA204634- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ETHACRYNATE SODIUM
- Generic name
- Ethacrynate Sodium
- Active ingredients
- ETHACRYNATE SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- MYLAN INSTITUTIONAL
- First approval
- 2016-08-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown